Home » today » Health » Paxlovid and molnupiravir – Here’s what to expect from Covid treatments Paxlovid and molnupiravir – Here’s what to expect from Covid treatments November 18, 2021 by world today news – Here’s what to expect from Covid treatments Pills to swallow at the first symptoms are announced by pharma giants. Who will benefit from it? Four-point lighting. – Posted: 11/17/2021, 8:27 p.m.— – Molnupiravir capsules from Merck. According to the first results communicated by the company, this antiviral reduces by approximately half the risk of hospitalization, if it is taken at the beginning of the disease. AFP They have names to sleep outside. But we forgive them, because they bring hope. Two antivirals have just appeared in the fight against Covid. Pfizer announced on Tuesday that it had requested urgent authorization in the United States for its drug called paxlovid, a treatment administered orally within three days of onset of symptoms. On November 5, unennew to already caused a sensation: the company revealed that this first antiviral developed specifically against Covid makes it possible to prevent hospitalization or death by 89% in adults with a high risk of developing a serious form of the disease. — Related posts:Successful vaccination day in Zacatecas: more than 13,000 girls and boys have been vaccinated on the...5 health benefits of vitamin B6 .. including improving immunity and heart healthHubble has identified an unusual wrinkle in the universe's expansion rateSurveillance Colonoscopy in Elderly Patients: Finding Few Advanced Adenomas or Colon CancerShare this:FacebookX Related Spotify podcast subscriptions open in 33 new countries Tauron’s net profit is higher than estimated, lower than last year Leave a Comment Cancel replyCommentName Email Website Save my name, email, and website in this browser for the next time I comment. Δ This site uses Akismet to reduce spam. Learn how your comment data is processed. Search for: